Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June September July August
Previous Archive
18 April 2024 | Story Andre Damons | Photo Charl Devenish
Dr Osayande Evbuomwan
Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine at the University of the Free State (UFS), received the first clinical PhD in nuclear medicine completed at the UFS at the April graduation ceremonies.

Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine, Faculty of Health Sciences, at the University of the Free State (UFS), graduated with the first clinical PhD in nuclear medicine completed at the UFS.

He graduated on Thursday (18 April 2024) at the university’s autumn graduation ceremonies when the Faculty of Health Sciences conferred degrees on its graduation class of 2024.

Dr Evbuomwan, the man behind his department using Lutetium 177 PSMA (Lu-177 PSMA) therapy and now Actinium 225 PSMA therapy to treatment metastatic castrate resistant prostate cancer (MCRPC) – an advanced stage prostate cancer, said his PhD is about using a special radiopharmaceutical called Technetium 99m ECDG to detect active disease in the joints of patients with rheumatoid arthritis (RA).

More opportunities for similar degrees

This research has won him the Society of Nuclear Medicine and Molecular Imaging (SNMMI) International Best Abstract Award for South Africa during last year’s SNMMI 2023 Annual Meeting in the US.

“I am very grateful, and at the same time, proud about this achievement (his PhD). This qualification will definitely give more opportunities for further similar degrees at the department. So yes, I feel very happy and fulfilled.

“Rheumatoid arthritis is a debilitating disease with associated morbidity that can lead to serious joint deformity and destruction. The need for an investigation with a very high diagnostic accuracy in detecting active disease is needed, especially in the detection of subclinical disease. Few prior studies in the literature had shown promising results with Tc 99m ECDG imaging in this regard. So, we decided to conduct a proper prospective study to test this hypothesis,” says Dr Evbuomwan.

This research, he explains, was also aimed at finding out if the new nuclear medicine radiopharmaceutical for the identification of active disease in patients with rheumatoid arthritis can also offer prognostic information. This aspect of the study concluded that this particular radiopharmaceutical (Tc – 99m ECDG) is highly sensitive in identifying synovitis (inflammation of the membrane that protects joints) and is capable of offering prognostic information in patients with rheumatoid arthritis.

This was the first prospective study to assess the prognostic value of this radiopharmaceutical in patients with rheumatoid arthritis, Dr Evbuomwan says.

Researching theranostics in the future

According to him, he had a smooth journey to completing his PhD – something he contributes to support from the fantastic team of three supervisors, the assistant who prepared the radiopharmaceutical, the rheumatology department, the radiographers and nurses at the Department of Nuclear Medicine, and most importantly, his wife and two daughters.

His passion for research, growth and the practice of nuclear medicine were his major motivators on this journey.

Dr Evbuomwan is currently looking at the possibility of starting research on theranostics. The only stumbling block for now, he says, is that the department still does not have a PET/CT camera, as this is very vital in today’s nuclear medicine practice. However, together with the Free State Department of Health, they are working hard to secure one.

“I now want to focus on nuclear medicine therapy and its promotion. This includes both imaging and treatment (theranostics) of certain cancers, most especially prostate cancer, neuroendocrine neoplasms, thyroid cancers and the neuroectodermal tumours. I also want to focus on being involved with the training of more registrars at the department of nuclear medicine and increasing the awareness of nuclear medicine amongst colleagues in the Free State,” says Dr Evbuomwan about his future plans. 

News Archive

UFS Council appoints agency to assist with its residence integration policy
2008-06-06

The Council of the University of the Free State (UFS) has appointed the Cape Town based iGubu Leadership Agency to assist with its residence integration policy.

“The agency will assist management in understanding and identifying the current obstacles related to the implementation of the residence integration policy, draw up proposals to enhance and successfully implement this integration policy, and implement these proposals to ensure successful integration within the 21 residences on the Main Campus in Bloemfontein,” says Prof. Teuns Verschoor, Acting Rector of the UFS.

The agency was appointed after an intensive advertising, screening and interviewing process was conducted by the university’s management. A recommendation on the successful candidate was subsequently made to the Council and the iGubu Leadership Agency was informed of its appointment this past week,” says Prof. Verschoor.

“Some of the projects that we have been involved in include the development and management of student leadership at among others the universities of Stellenbosch and Cape Town as well as the Huguenot College, and leadership initiatives such as the Beeld Youth Summit and last year’s Brightest Young Minds conference,” says Mr Rudi Buys, Chief Executive Officer. He will be working with Mr Yeki Mosomothane, Strategy Manager of the agency and a diverse team of facilitators.

Their main focus will be on investigating the trust relationships between stakeholders, establishing healthy relationships between students and the development of the skills of student leaders to establish conversations on values and meaningful change in residences and the student community.

“In the first phase of the project we will be conducting research and talk to students and other role players regarding ways of building unity on campus. After that the kind of programmes that may be implemented to further integration in residences will be determined together with stakeholders and the most suitable ones will be implemented. We will emphasise ownership and participation of processes by students and other stakeholders to ensure sustainability,” says Mr Buys.

The contract is for two and a half years and the agency must regularly report to Council via management on its progress. “We see this appointment as an investment in the integration of our residences and look forward to the interventions iGubu Leadership Agency can bring to the table,” says Prof. Verschoor.

The agency specialises in mentoring individuals and teams and in facilitating the participation of communities in transformation and reconciliation initiatives in specifically an African context, and does so from a leadership development perspective. The agency has extensive experience in facilitating programmes for diversity and integration.

iGubu Leadership Agency’s appointment goes hand in hand with the appointment of other agencies who will support management and make recommendations on how to accelerate transformation and position the UFS as an engaged and responsive university.

Media Release
Issued by: Lacea Loader
Assistant Director: Media Liaison
Tel:  051 401 2584
Cell:  083 645 2454
E-mail:  loaderl.stg@ufs.ac.za
6 June 2008

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept